A clinical and laboratory study evaluating the profile of cytokine levels in relapsing remitting and secondary progressive multiple sclerosis
Author:
Funder
Fondazione Cassa di Risparmio di Lucca
Publisher
Elsevier BV
Subject
Clinical Neurology,Neurology,Immunology,Immunology and Allergy
Reference39 articles.
1. Th17 cells in immunity and autoimmunity;Bedoya;Clin. Dev. Immunol.,2013
2. Possible role of transforming growth factor-beta in relapsing–remitting multiple sclerosis;Carrieri;Neurol. Res.,1997
3. Profile of cerebrospinal fluid and serum cytokines in patients with relapsing–remitting multiple sclerosis: a correlation with clinical activity;Carrieri;Immunopharmacol. Immunotoxicol.,1998
4. Serum levels of interleukin (IL)-18, IL-23 and IL-17 in Chinese patients with multiple sclerosis;Chen;J. Neuroimmunol.,2012
5. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes;De Waal Malefyt;J. Exp. Med.,1991
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Biomarkers Differentiating RRMS and SPMS in Multiple Sclerosis—A Systematic Review;Sclerosis;2024-07-31
2. Histamine H4 Receptor Agonist, 4-Methylhistamine, Aggravates Disease Progression and Promotes Pro-Inflammatory Signaling in B Cells in an Experimental Autoimmune Encephalomyelitis Mouse Model;International Journal of Molecular Sciences;2023-08-20
3. A coffee enriched with guarana, selenium, and l-carnitine (GSC) has nutrigenomic effects on oxi-inflammatory markers of relapsing-remitting multiple sclerosis patients: A pilot study;Multiple Sclerosis and Related Disorders;2023-03
4. Crosstalk between dendritic cells and regulatory T cells: Protective effect and therapeutic potential in multiple sclerosis;Frontiers in Immunology;2022-09-13
5. Circulating miRNAs as Potential Biomarkers Distinguishing Relapsing–Remitting from Secondary Progressive Multiple Sclerosis. A Review;International Journal of Molecular Sciences;2021-11-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3